BUSINESS● LOW3d ago · Oct 12, 2026, 8:59 AM
Biogen upgraded at JPMorgan with $300 PT on 2027 pipeline catalysts, shares rise
Seeking Alpha Tech · global
Biogen's stock was upgraded by JPMorgan with a $300 price target, attributed to potential pipeline catalysts in 2027, causing its shares to rise. This indicates positive market sentiment for the company's future.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS27m agoEqual-weight failed. Now tech stocks look shaky again. So what should you do about S&P 500 risk?CNBCBUSINESS33m agoBoeing’s stock slump draws Wall Street bulls amid risksSeeking Alpha Tech